Vigene Biosciences Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Vigene Biosciences's estimated annual revenue is currently $11M per year.
- Vigene Biosciences's estimated revenue per employee is $155,000
- Vigene Biosciences has 71 Employees.
- Vigene Biosciences grew their employee count by 15% last year.
- Vigene Biosciences currently has 5 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Pricing|
|American Gene T...||$4.7M||30||N/A||N/A||N/A|
What Is Vigene Biosciences?
Vigene Biosciences was founded in 2012 by senior scientists with expertise in the fields of virology and gene therapy. At Vigene, we strive to be the leading supplier of gene delivery technologies with the mission to advance biomedical research and to make gene therapy affordable. We offer both research-grade and cGMP-grade AAV, lentivirus, and adenovirus-based products and custom services. Some of our product offerings include ready-to-ship genome wide human cDNA ORFs on adenoviral or lentiviral vectors, AAV shRNA constructs, pre-made control GFP viruses, AAV biosensors developed in partnership with Janelia Research Campus, AAV alpha-synuclein vectors developed in partnership with The Michael J Fox Foundation, and many others. For more information, visit our websites for research (www.vigenebio.com) or cGMP (www.vigenegmp.com) services. You can also follow us on twitter at @VigeneBio.keywords:N/A
Number of Employees
Employee Growth %
|Man-Shiow Jiang||Senior Director, Process Development & Manufacturing Production||Email Available|
|Sean Kelly||Associate Director||Email Available|
|Lynn-Marie Lenhart||Sales Manager|
|Chris DeMello||Vice President Of Gmp Manufacturing||Email Available|
|Jenny Zhao||Director at Technical Transfer & Support||Email Available|
|Malena Ruiz||Senior Manager EHS & Operations||Email Available|
|Joanna Lathrop||Human Resources Director||Email Available|
|Rob Brennan||Business Development Manager||Email Available|
|Maurice Whitsett||Procurement Manager||Email Available|
|James Cody||Business Development Manager||Email Available|
Vigene Biosciences News
ROCKVILLE, Md., April 29, 2019 /PRNewswire/ -- Vigene Biosciences, Inc ("Vigene") a leading provider of viral vector products and services ...
... Gene Therapy (a unit of Catalent Biologics), the Chinese company WuXi Advanced Therapies, Novasep, Vigene Biosciences, and Virovek.
This is the first raise for the business, which has been profitable and fueled growth organically up to this point.
Vigene Biosciences Acquisitions
|2016-11-30||Omnia Biologics, Inc||Article|